London, UK (PRWEB) February 01, 2012
Which country should be chosen to conduct a clinical trial and which should be avoided? What are the conditions, pros and cons of conducting clinical trials in Russia, Ukraine, Belarus and Georgia? Which are the largest sponsors in the region, what kind of drugs are they currently investigating and which phases of clinical trials do they conduct? What are the largest CROs in the region? In which countries are delays expected during the registration of a clinical trial? What is the average time to register a clinical trial in particular countries? What are the most important legal regulations? Answers to all these questions and many more can be found in the research report.
New market research report “Clinical Trials in CIS Countries 2012” developed by PMR has been recently published by Market Publishers Ltd.
Title: Clinical Trials in CIS Countries 2012
Published: January 1, 2012
Price: US$ 2,800
The report focuses on clinical trial operating conditions in the following CIS countries – Russia, Ukraine, Belarus and Georgia, offering statistical data and analysis on the present-day market size with forecasts through 2014.
- market current and anticipated situation;
- market growth opportunities and obstacles;
- average registration time for clinical trials;
- major characteristics and market standing of top companies conducting clinical trials.
The study also includes a comparative analysis of conditions governing the performance of clinical trials in the CIS countries analyzed. The operations of major pharmaceutical corporations active in CIS are then presented, with special attention given to the number of trials, location, and therapeutic areas.
I. Report Methodology
II. Executive Summary
Iii. Size of the Clinical Trial Market in the CIS between 2004 and 2014
Iv. Comparative Analysis of Clinical Research Environments in the Selected CIS Countries
V. Analysis of Clinical Trials Conducted by International Concerns
Vi. Profiles of Selected Cros Operating on the CIS Market
Vii. Assessment of the CIS as a Location for Clinical Trials
VIII. Legislative Environment in the CIS Countries
Ix. List of Graphs
X. List of Tables
XI. About PMR
XII. Contact PMR
More new market research reports by the publisher can be found at PMR page.